ANMI
LIVE

Serial Number

79297420

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Aug 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ANMI Trademark

Serial Number: 79297420 • Registration: 6367058

ANMI is a trademark filed by Telix Pharmaceuticals Limited on August 26, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

August 26, 2020

Registration Date

June 1, 2021

Published for Opposition

March 16, 2021

Goods & Services

Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science all of the aforementioned in relation to radiopharmaceuticals and cancer

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer

Medical apparatus, namely, infusion and injection devices sold empty for administering drugs and diagnostic radiopharmaceuticals, namely, syringes; apparatus for medical purposes, namely, drug delivery devices sold empty for diagnostic radiopharmaceuticals, namely, syringes; medical devices for treating cancer; diagnostic imaging apparatus for medical use

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 1, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 25, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 23, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 23, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 1, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 1, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 15, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
REFUSAL PROCESSED BY IB
Feb 14, 2021 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2021 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 25, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 25, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 5, 2021 RFCR
APPLICATION FILING RECEIPT MAILED
Jan 5, 2021 MAFR
NON-FINAL ACTION WRITTEN
Jan 4, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 28, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 5, 2020 REPR